Back to Top Skip to main content Skip to sub-navigation

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Defending the Homeland: Regional Health Command-Atlantic staff treat COVID-19 patients at NJ hospital

Article
5/27/2020
Three people in scrubs around a patient on a hospital bed

The officers assigned to the program were selected because they have medical specialties typically used in military forward surgical teams.

Recommended Content:

Coronavirus

Foreign liaison officers bring new perspective to MHS

Article
5/26/2020
Image of three men talking to each other

Medical information exchange aids in better care everywhere

Recommended Content:

Global Health Engagement | Coronavirus | Global Health Engagement

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

Publication
5/26/2020

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Recommended Content:

Coronavirus

COVID-19: lifestyle tips to stay healthy during the pandemic

Article
5/22/2020
Collage of four pictures of people exercising, sleeping and eating healthy food

With this unprecedented lifestyle shift, there is a potential for the normalization of a more sedentary lifestyle.

Recommended Content:

Coronavirus

Using mobile mental health apps to cope during social isolation

Article
5/22/2020
Soldier holding cell phone, showing app to another person

Learn how your smartphone can serve as a lifeline

Recommended Content:

Coronavirus | Public Health | Depression | Connected Health | Total Force Fitness

Medical maintainers play key role in Army’s response to COVID-19

Article
5/22/2020
Soldier looking at medical equipment on shelves

In the field, Soldiers trained as Biomedical Equipment Specialists, or 68As, handle unit-level sustainment of deployed medical devices.

Recommended Content:

Coronavirus

Air Force bioenvironmental engineers expand mission in aerovac, workspaces

Article
5/21/2020
Military Captain and team cleaning large, plastic enclosed space

The aeromedical evacuation mission became a top priority as COVID-19 began to spread.

Recommended Content:

Coronavirus | Public Health

Defending the Homeland: NMHM opens ‘virtual doors’ to the public during COVID-19

Article
5/21/2020
Image of two rows of empty hospital beds in the early 1900s

In the current climate of COVID-19 and stay-at-home orders, virtual environments have become an invaluable means of entertainment and education.

Recommended Content:

Coronavirus | National Museum of Health and Medicine

VENDOR UNSOLICITED PROPOSAL IN SUPPORT OF COVID-19

Form/Template
5/21/2020

Unsolicited Proposal Information Supporting COVID-19

Recommended Content:

Component Acquisition Executive | Coronavirus

Defending the Homeland: NHB/NMRTC Bremerton’s PHEO leans in on COVID-19 pandemic

Article
5/20/2020
Three men standing in front of a military medical tent

It’s been long days preparing for the unpredictable, limiting the unforeseen and controlling the unexpected.

Recommended Content:

Coronavirus | Heroes Behind the Mask

Guidance for Commanders on Risk-Based Changing of Health Protection Condition Levels During the Coronavirus Disease 2019 Pandemic

Publication
5/20/2020

This memorandum provides guidance for commanders to consider when making decisions to change health protection condition (HPCON) levels as COVID-19 pandemic conditions on and adjacent to our installations begin to improve.

Recommended Content:

Coronavirus

Military chaplains emphasize spiritual health during COVID-19 pandemic

Article
5/19/2020
Soldier in front of military sculpture

In a time of great fear, spiritual health remains an important domain of Total Force Fitness.

Recommended Content:

Coronavirus | Psychological Fitness | Total Force Fitness

DHA increases access to telehealth during COVID-19 pandemic

Article
5/19/2020
Medical personnel sitting at desk talking into laptop monitor

Use of telehealth role increases to prevent COVID-19 spread

Recommended Content:

TRICARE Health Program | Coronavirus

METC creates innovative training to graduate RT students

Article
5/19/2020
Two medical personnel with a simulated baby in a medical setting

When COVID-19 interrupted phase 2 clinical training a class of Army and Navy respiratory therapist students needed to from the program, their clinical training instructors developed a plan and put it to action.

Recommended Content:

Coronavirus

Resuming Elective Surgical, Invasive, and Dental Procedures in Military Medical and Dental Treatment Facilities

Publication
5/19/2020

This memorandum provides guidance on how each Military Medical Treatment Facility (MTF) and Dental Treatment Facility (DTF) may resume elective medical and dental procedures.

Recommended Content:

Public Health | Coronavirus
<< < ... 21 22 23 24 25  ... > >> 
Showing results 361 - 375 Page 25 of 34

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.